002919 名臣健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.6353.4725.7219.0833.391
总资产报酬率 ROA (%)-0.4042.3713.9305.5902.294
投入资产回报率 ROIC (%)-0.5323.0335.0377.3832.897

边际利润分析
销售毛利率 (%)57.59754.12152.50060.26752.500
营业利润率 (%)-1.0393.6152.2703.538-0.577
息税前利润/营业总收入 (%)-0.7793.6371.9793.5261.102
净利润/营业总收入 (%)-0.8391.8363.3854.2972.686

收益指标分析
经营活动净收益/利润总额(%)147.47434.919365.231167.553-117.502
价值变动净收益/利润总额(%)-7.544192.1071.9060.1464.888
营业外收支净额/利润总额(%)1.428-2.073-14.022-2.303135.794

偿债能力分析
流动比率 (X)1.7101.6932.5981.9641.442
速动比率 (X)1.5241.5272.2991.4871.010
资产负债率 (%)35.89437.20525.37836.43140.520
带息债务/全部投入资本 (%)9.57014.0724.26014.57713.572
股东权益/带息债务 (%)901.143578.3432,209.762566.783588.516
股东权益/负债合计 (%)179.271168.886294.039174.490146.793
利息保障倍数 (X)-2.83737.933-167.64851.930-2.156

营运能力分析
应收账款周转天数 (天)39.01454.24175.16354.50670.631
存货周转天数 (天)34.77239.31779.034110.557129.989